SOFW SOFWAVE MEDICAL LTD

Sofwave Receives FDA Clearance for Pure Impact™ in Strengthening and Firming of Arms in the U.S.

Sofwave Receives FDA Clearance for Pure Impact™ in Strengthening and Firming of Arms in the U.S.

  • Latest Pure Impact™ indication expansion includes strengthening and improvement in muscle tone and firmness of the arms
  • Represents next major step toward Pure Impact™ covering multiple body areas and muscles
  • Complements Sofwave’s SUPERB’s current claim to improve the appearance of skin laxity on the upper arm and provides a complete approach to arm treatments
  • Launch of Pure Impact™ Arms will be supported by the “Sofwave Endless Summer” marketing campaign

SAN CLEMENTE, Calif., Aug. 12, 2024 (GLOBE NEWSWIRE) -- Sofwave Medical Ltd (“the Company”) (TASE: SOFW), an emerging leader in energy-based non-invasive, aesthetic medical devices, announced today that the Company has received 510(k) premarket notification clearance from the U.S. Food and Drug Administration (FDA) to expand the use of Pure Impact™ in strengthening and improvement in muscle tone and firmness sculpting of the arms.

“Pure Impact™ remains the world’s first plyometric muscle activation device, emulating a variety of complex and compound full-body muscle movements,” noted Louis Scafuri, CEO of Sofwave Medical. “The inclusion of Pure Impact™ plyometrics for the arms enables the emulation of complex upper body cardio-muscular high-intensity interval training workouts, such as burpees and star jumps. Importantly, we believe that Sofwave plus Pure Impact provides an enhancement of physical appearance in conjunction with diet and exercise regimens. As patients age or lose weight, Pure Impact™ Arms contributes to increased tone, and decreased overall arm laxity. Pure Impact’s most recent FDA clearance for strength toning and firmness of the arms is the next major step toward the achievement of total body muscle activation harnessing the power of our PlyoPulse™ electric muscle stimulation technology.”

“It is readily evident that Pure Impact™ was developed by expert physiologists,” said board-certified dermatologist Dr. Jessica Weiser, whose practice resides in New York City. “My patients love the emulation of whole-body plyometric exercises as it not only emphasizes functional core strength and improved posture, but also yields a more sculpted physical appearance in patients through plyometric muscle activation. Pure Impact™ is unlike any previous muscle activation device; we proactively and preventatively integrate treatment into my patients’ wellness journeys. Sofwave plus Pure impact is the ideal treatment for GLP-1 patients to directly counter the risk of muscle loss from inactivity or aging (sarcopenia).“

Pure Impact™ Arms will be supported by the launch of the “Sofwave Endless Summer marketing campaign. Not only can the Sofwave system be used to improve dermal laxity of the arms, but the increased muscle tone achieved with Pure Impact™ module significantly enhances both aesthetic and functional results, making Sofwave plus Pure Impact™ Arms, the ultimate treatment package for anyone looking to improve their look and feel stronger.

About Sofwave Medical

 has implemented an innovative approach to wrinkle reduction lifting and cellulite using its proprietary breakthrough technology. SUPERB™, Synchronous Ultrasound Parallel Beam technology, is FDA-cleared to improve facial lines and wrinkles, lifting the eyebrow and lifting lax submental tissue (beneath the chin), lifting lax skin in the arms, as well as the short-term improvement in the appearance of cellulite and treatment of acne scars. The company’s Pure Impact™ module uses EMS technology and is cleared for muscle toning. Sofwave’s products provide physicians with smart yet simple, effective, and safe aesthetic solutions for their patients. Contact: 

Investor Contact:

Brian Ritchie

LifeSci Advisors LLC

(212) 915-2578



EN
12/08/2024

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on SOFWAVE MEDICAL LTD

 PRESS RELEASE

Sofwave Receives FDA, Pre-market Clearance for Pure Impact VIPTM Stand...

Sofwave Receives FDA, Pre-market Clearance for Pure Impact VIPTM Standalone EMS Device For Comprehensive Multi-Body Area Muscle Strengthening and Firming The Pure Impact VIP™ standalone device represents a major extension of the Pure Impact™ product line and introduces an all-in-one independent unitStandalone device is launched with an enhanced Pure Impact™ feature set which provides comprehensive muscle strengthening programs that focus on multiple body areas including the: abdomen, arms, thighs, and buttocks and enables simultaneous treatment of 6 muscle groupsIn the recent McKinsey Life ...

 PRESS RELEASE

Sofwave to Participate in 10th Annual Needham Virtual MedTech & Diagno...

Sofwave to Participate in 10th Annual Needham Virtual MedTech & Diagnostics Conference SAN CLEMENTE, Calif., Aug. 06, 2025 (GLOBE NEWSWIRE) -- Sofwave Medical Ltd (“the Company”) (TASE: SOFW), an emerging leader in energy-based non-invasive, aesthetic medical devices for practitioners worldwide, today announced that Louis Scafuri, Chief Executive Officer, and Assaf Korner, Chief Financial Officer, will participate in the 10th Annual Needham Virtual MedTech & Diagnostics 1×1 Conference on August 11 – 12, 2025. About Sofwave Medical has implemented an innovative approach to wrinkle reducti...

 PRESS RELEASE

Sofwave Medical Reports Record Second Quarter and First Half 2025 Fina...

Sofwave Medical Reports Record Second Quarter and First Half 2025 Financial Results and Business Highlights • Quarterly record revenue in Q2 of $21M, +43% year-over-year growth; IFRS gross margin of 75.5% • Second quarter pulse recurring revenue of $9.2M, +53% year-over-year growth • First half revenue of $37.6M, +35% year-over-year growth; IFRS gross margin of 75.9% • Generated $3.6M in cash in the second quarter • Positive first half and second quarter IFRS and Non-IFRS operating and net income vs first half loss in the same year ago period • Over 600,000 treatments completed since i...

 PRESS RELEASE

Sofwave to Participate in Jefferies Global Healthcare Conference

Sofwave to Participate in Jefferies Global Healthcare Conference SAN CLEMENTE, Calif., May 22, 2025 (GLOBE NEWSWIRE) -- Sofwave Medical Ltd (“the Company”) (TASE: SOFW),  an emerging leader in energy-based non-invasive, aesthetic medical devices for practitioners worldwide, today announced that Assaf Korner, Chief Financial Officer, will provide a corporate overview and participate in one-on-one investor meetings at the Jefferies Global Healthcare Conference, to be held in New York from June 3-5, 2025. Jefferies Global Healthcare ConferencePresentation Format: Corporate overviewPresentat...

 PRESS RELEASE

Sofwave Medical Reports First Quarter Fiscal 2025 Financial Results an...

Sofwave Medical Reports First Quarter Fiscal 2025 Financial Results and Business Highlights — First quarter revenue of $16.7M, +26% year-over-year growth; IFRS gross margin of 76.3%— First quarter pulse recurring revenue of $7.0M, +49% year-over-year growth— IFRS and non-IFRS operating loss of -$1M and -$0.2M, respectively SAN CLEMENTE, Calif., May 06, 2025 (GLOBE NEWSWIRE) -- Sofwave Medical Ltd (TASE: SOFW), an emerging leader in energy-based non-invasive, aesthetic medical devices for practitioners worldwide, reported financial results for the first quarter of fiscal year 2025, for th...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch